MENLO PARK, Calif., May 25, 2023 /PRNewswire/ -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, announced today that it will be participating in the following upcoming investor conferences:
- Bernstein's 39th Annual Strategic Decisions Conference on Thursday, June 1, 2023, at 2:30 PM ET in New York, NY
- Goldman Sachs 44th Annual Global Healthcare Conference on Tuesday, June 13, 2023, at 8:00 AM PT in Dana Point, CA
Live webcasts of the events can be accessed at the company's investors page at investor.pacificbiosciences.com. Webcast replays will be available for at least 30 days following the event.
Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing, and manufacturing advanced sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. Our products and technology under development stem from two highly differentiated core technologies focused on accuracy, quality, and completeness, which include our existing HiFi long-read sequencing technology and our emerging short-read Sequencing by Binding (SBB™) technology. Our products address solutions across a broad set of applications, including human genomics, plant and animal sciences, infectious disease and microbiology, oncology, and other emerging applications. For more information, please visit www.pacb.com and follow @PacBio.
PacBio products are provided for research use only. Not for use in diagnostic procedures.
View original content to download multimedia:https://www.prnewswire.com/news-releases/pacbio-to-present-at-upcoming-investor-conferences-301834648.html
SOURCE Pacific Biosciences of California, Inc.